Black Diamond Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Black Diamond Therapeutics, Inc. has filed 483 SEC EDGAR filings since 28 Mar 2017

SEC filing history

Showing 401-425 of 483 matching filings.

Per page
25
Current page
17
4

FORM 4 SUBMISSION

Filing date
14 Aug 2020
Reporting date
12 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Aug 2020
Reporting date
12 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39200

8-K

Filing date
11 Aug 2020
Reporting date
11 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jul 2020
Reporting date
27 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jul 2020
Reporting date
27 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39200

8-K

Filing date
12 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39200

8-K

Filing date
24 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91312

SC 13D

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91312

SC 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91312

NEW ENTERPRISE ASSOCIATES 16, L.P. - BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91312

SC 13D

Filing date
05 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39200

8-K

Filing date
03 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .